The continuing problem of sepsis-following enzymatic debridement of burns.
D000293:Adolescent; D001412:Bacillus subtilis / Q000201:enzymology; D002056:Burns / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D003013:Clostridium / Q000201:enzymology; D003646:Debridement; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007709:Klebsiella / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000009:adverse effects* / Q000627:therapeutic use; D011513:Proteus mirabilis / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology*; D013291:Streptococcus / Q000302:isolation & purification; D013411:Sulfadiazine / Q000627:therapeutic use
D010406:Penicillins; D013411:Sulfadiazine; D010447:Peptide Hydrolases